Abstract
Purpose
To evaluate the effects of newer sublingual desmopressin administration in lithiasic renal colic, alone or combined with a nonsteroidal anti-inflammatory drug (NSAID).
Methods
Prospective single-blind study including an initial number of 249 patients with lithiasic renal colic was randomized as follows: group NSAID (71 patients) received ketorolac tromethamine (ketorolac) 30 mg im and sublingual placebo (vitamin C), groups D1 and D2 (57 and 62 patients) received sublingual desmopressin (Minirin Melt), 60 and 120 μg, respectively, whereas group C (59 patients) received a combination of 30 mg im ketorolac and 60 μg sublingual desmopressin. Pain intensity was assessed using the visual analogue scale before and thirty minutes after drug administration. Patients experiencing pain aggravation were rescued and excluded from the study.
Results
Dropout incidence was higher in the NSAID group than in the groups treated with desmopressin in monotherapy or combined with ketorolac (p < 0.05). Pain intensity was diminished at least as potently by the monotherapy with desmopressin and ketorolac. The higher dose of desmopressin and the combination therapy decreased pain intensity with 56 and 59 %, respectively, significantly more than the 47 % decrease obtained with ketorolac alone (p < 0.05 and p < 0.001). Mean pain decrease was higher in the combination group (C) than in the NSAID or D1 groups (p < 0.001 and p < 0.05, respectively), suggesting drug additivity. Patients did not experience severe side effects.
Conclusions
Sublingual desmopressin is at least as potent as NSAID in the treatment of lithiasic renal colic. The combination of sublingual desmopressin and NSAID has additive analgesic effects.
Similar content being viewed by others
References
Fisang C, Anding R, Müller SC, Latz S, Laube N (2015) Urolithiasis - an interdisciplinary diagnostic, therapeutic and secondary preventive challenge. Dtsch Arztebl Int 112:83–91. doi:10.3238/arztebl.2015.0083
Pedersen KV, Liao D, Osther SS, Drewes AM, Gregersen H, Osther PJ (2012) Distension of the renal pelvis in kidney stone patients: sensory and biomechanical responses. Urol Res 40:305–316. doi:10.1007/s00240-011-0425-3
Carter MR, Green BR (2011) Renal calculi: emergency department diagnosis and treatment. Emerg Med Pract 13:1–17
Dahan A, Olofsen E, Niesters M (2015) Pharmacotherapy for pain: efficacy and safety issues examined by subgroup analyses. Pain 156:S119–S126. doi:10.1016/j.pain.0000000000000023
Brune K, Patrignani P (2015) New insights into the use of currently available non-steroidal anti-inflammatory drugs. J Pain Res 20:105–118. doi:10.2147/JPR.S75160
Jamison RN, Mao J (2015) Opioid analgesics. Mayo Clin Proc 90:957–968. doi:10.1016/j.mayocp.2015.04.010
Brown D, Bouley R, Păunescu TG, Breton S, Lu HA (2012) New insights into the dynamic regulation of water and acid-base balance by renal epithelial cells. Am J Physiol Cell Physiol 30:1421–1433. doi:10.1152/ajpcell.00085.2012
Marumo F, Edelman IS (1971) Effects of Ca++ and prostaglandin E1 on vasopressin activation of renal adenyl cyclase. J Clin Invest 50:1613–1620
El-Sherif AE, Salem M, Yahia H, Al-Sharkawy WA, Al-Sayrafi M (1995) Treatment of renal colic by desmopressin intranasal spray and diclofenac sodium. J Urol 153:1395–1398
Grenabo L, Aurell M, Delin K, Holmlund D, Sjödin JG (1983) Antidiuretic hormone levels and the effect of indomethacin on ureteral colic. J Urol 129:941–943
Moro U, De Stefani S, Crisci A, De Antoni P, Scott CA, Selli C (1999) Evaluation of the effects of desmopressin in acute ureteral obstruction. Urol Int 62:8–11
Kimoto Y, Constantinou CE (1990) Effects of [1-desamino-8-d-arginine] vasopressin and papaverine on rabbit renal pelvis. Eur J Pharmacol 175:359–362
Mavani GP, DeVita MV, Michelis MF (2015) A review of the nonpressor and nonantidiuretic actions of the hormone vasopressin. Front Med (Lausanne) 2:19. doi:10.3389/fmed.2015.00019
Constantinides C, Kapralos V, Manousakas T, Mitropoulos D, Alamanis C, Dimopoulos C (1998) Management of renal colic with intranasal desmopressin spray. Acta Urol Belg 66:1–3
Lopes T, Dias JS, Marcelino J, Varela J, Ribeiro S, Dias J (2001) An assessment of the clinical efficacy of intranasal desmopressin spray in the treatment of renal colic. BJU Int 87:322–325
Kheirollahi AR, Tehrani M, Bashashati M (2010) A comparison of the effect of intranasal desmopressin and intramuscular hyoscine N-butyl bromide combination with intramuscular hyoscine N-butyl bromide alone in acute renal colic. J Res Med Sci 15:214–218
Roshani A, Falahatkar S, Khosropanah I et al (2010) Assessment of clinical efficacy of intranasal desmopressin spray and diclofenac sodium suppository in treatment of renal colic versus diclofenac sodium alone. Urology 75:540–542. doi:10.1016/j.urology.2008.05.053
Masoumi K, Asgari Darian A, Forouzan A et al (2014) The efficacy of intranasal desmopressin as an adjuvant in the acute renal colic pain management. Pain Res Treat. doi:10.1155/2014/320327
Kumar S, Behera NC, Sarkar D, Prasad S, Mandal AK, Singh SK (2011) A comparative assessment of the clinical efficacy of intranasal desmopressin spray and diclofenac in the treatment of renal colic. Urol Res 39:397–400. doi:10.1007/s00240-010-0354-6
Hazhir S, Badr YA, Darabi JN (2010) Comparison of intranasal desmopressin and intramuscular tramadol versus pethidine in patients with renal colic. Urol J 7:148–151
Keshvari Shirvani M, Darabi Mahboub M, Ghazi M, Delijani A (2015) A comparison of the effects of morphine and sublingual desmopressin combination therapy with morphine alone in treatment of renal colic: a controlled clinical trial. Urol J 12:2001–2004
Juul KV, Schroeder MK, Rittig S, Nørgaard JP (2015) Desmopressin as an adjuvant to opioids or NSAIDs in treatment of renal colic: a nationwide register-based study. Pharmacoepidemiol Drug Saf. doi:10.1002/pds.3875
Ebell MH, Radke T, Gardner J (2014) A systematic review of the efficacy and safety of desmopressin for nocturia in adults. J Urol 192(3):829–835. doi:10.1016/j.juro.03.095
Ohnhaus EE, Adler R (1975) Methodological problems in the measurement of pain: a comparison between the verbal rating scale and the visual analogue scale. Pain 1:379–384
Fransén N, Bredenberg S, Björk E (2009) Clinical study shows improved absorption of desmopressin with novel formulation. Pharm Res 26:1618–1625. doi:10.1007/s11095-009-9871-9
Al-Waili NS (1986) Prostaglandin synthetase inhibition with indomethacin rectal suppositories in the treatment of acute and chronic urinary calculus obstruction. Clin Exp Pharmacol Physiol 13:195–199
Wolfson AB, Yealy DM (1991) Oral indomethacin for acute renal colic. Am J Emerg Med 9:16–19
Yang J, Yuan H, Chu J et al (2009) Arginine vasopressin antinociception in the rat nucleus raphe magnus is involved in the endogenous opiate peptide and serotonin system. Peptides 30:1355–1361. doi:10.1016/j.peptides.2009.03.014
Stegner H, Artman HG, Leake RD, Fisher DA (1983) Does DDAVP (1-desamino-8-d-arginine-vasopressin) cross the blood-CSF barrier? Neuroendocrinology 37:262–265
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors (Cătălin Pricop, Dumitru D. Brănișteanu, Martha Orsolya, Dragoș Puia, Anca Matei and Ionel Alexandru Checheriță) declare that they have no conflict of interest.
Human and animal rights
All procedures performed in our study involving human participants were in accordance with the ethical standards of the institutional committees of the two involved universities and with the 1964 Declaration of Helsinki and its later amendments. This article does not contain any studies with animals performed by any of the authors.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Pricop, C., Branisteanu, D.D., Orsolya, M. et al. Sublingual desmopressin is efficient and safe in the therapy of lithiasic renal colic. Int Urol Nephrol 48, 183–189 (2016). https://doi.org/10.1007/s11255-015-1173-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-015-1173-z